Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06272149 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 22, 2024 (before its estimated January 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This exploratory trial is to prove the tolerability and safety of VGN-R08b to treat infants with type II Gaucher disease.
Trial Details
NCT Number NCT06272149
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators: Shanghai Vitalgen BioPharma Co., Ltd.
Conditions
(from sponsor)		 Type II Gaucher Disease
Related terms Gaucher Disease
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov